IL1B and bronchopulmonary dysplasia: We showed that at a dose of 10 mg/kg, the endogenous inhibitor of IL‐1, interleukin‐1 receptor antagonist (IL‐1Ra), ameliorates murine BPD induced by perinatal inflammation and hyperoxia 15.